These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 16092073)

  • 1. Parkinson's disease: a broken nosology.
    Hardy J; Lees AJ
    Mov Disord; 2005 Aug; 20 Suppl 12():S2-4. PubMed ID: 16092073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteolytic stress: a unifying concept for the etiopathogenesis of Parkinson's disease.
    McNaught KS; Olanow CW
    Ann Neurol; 2003; 53 Suppl 3():S73-84; discussion S84-6. PubMed ID: 12666100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetics of Parkinsonism: a review.
    Vaughan JR; Davis MB; Wood NW
    Ann Hum Genet; 2001 Mar; 65(Pt 2):111-26. PubMed ID: 11427172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of familial Parkinson's disease and parkinsonism to the understanding of nigral degeneration in sporadic Parkinson's disease.
    Hattori N; Shimura H; Kubo S; Wang M; Shimizu N; Tanaka K; Mizuno Y
    J Neural Transm Suppl; 2000; (60):101-16. PubMed ID: 11205133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synphilin-1 is present in Lewy bodies in Parkinson's disease.
    Wakabayashi K; Engelender S; Yoshimoto M; Tsuji S; Ross CA; Takahashi H
    Ann Neurol; 2000 Apr; 47(4):521-3. PubMed ID: 10762166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha synuclein is present in Lewy bodies in sporadic Parkinson's disease.
    Mezey E; Dehejia AM; Harta G; Tresser N; Suchy SF; Nussbaum RL; Brownstein MJ; Polymeropoulos MH
    Mol Psychiatry; 1998 Nov; 3(6):493-9. PubMed ID: 9857974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration in alpha-synuclein mRNA expression in Parkinson's disease.
    Kingsbury AE; Daniel SE; Sangha H; Eisen S; Lees AJ; Foster OJ
    Mov Disord; 2004 Feb; 19(2):162-70. PubMed ID: 14978671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The mechanism of Lewy body formation in Parkinson's disease].
    Wakabayashi K; Takahashi H
    Nihon Rinsho; 2000 Oct; 58(10):2022-7. PubMed ID: 11068441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.
    Conway KA; Harper JD; Lansbury PT
    Nat Med; 1998 Nov; 4(11):1318-20. PubMed ID: 9809558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathology of familial Parkinson's disease].
    Wakabayashi K; Takahashi H
    Brain Nerve; 2007 Aug; 59(8):851-64. PubMed ID: 17713121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons.
    Hill WD; Arai M; Cohen JA; Trojanowski JQ
    J Comp Neurol; 1993 Mar; 329(3):328-36. PubMed ID: 8459049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Update on the pathophysiology of Parkinson' disease].
    Duyckaerts C; Sazdovitch V; Seilhean D
    Bull Acad Natl Med; 2010 Oct; 194(7):1287-303; discussion 1303-4. PubMed ID: 22043625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aggregation of neurofilament and alpha-synuclein proteins in Lewy bodies: implications for the pathogenesis of Parkinson disease and Lewy body dementia.
    Trojanowski JQ; Lee VM
    Arch Neurol; 1998 Feb; 55(2):151-2. PubMed ID: 9482355
    [No Abstract]   [Full Text] [Related]  

  • 14. [Parkinson's disease: what have we learned from the genes responsible for familial forms?].
    Corti O; Brice A
    Med Sci (Paris); 2003 May; 19(5):613-9. PubMed ID: 12836396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A possible role for humoral immunity in the pathogenesis of Parkinson's disease.
    Orr CF; Rowe DB; Mizuno Y; Mori H; Halliday GM
    Brain; 2005 Nov; 128(Pt 11):2665-74. PubMed ID: 16219675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic approach to studying Parkinson's disease.
    Zhang J; Goodlett DR
    Mol Neurobiol; 2004 Jun; 29(3):271-88. PubMed ID: 15181239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
    Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H
    J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-synuclein has an altered conformation and shows a tight intermolecular interaction with ubiquitin in Lewy bodies.
    Sharma N; McLean PJ; Kawamata H; Irizarry MC; Hyman BT
    Acta Neuropathol; 2001 Oct; 102(4):329-34. PubMed ID: 11603807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stage-dependent nigral neuronal loss in incidental Lewy body and Parkinson's disease.
    Dijkstra AA; Voorn P; Berendse HW; Groenewegen HJ; ; Rozemuller AJ; van de Berg WD
    Mov Disord; 2014 Sep; 29(10):1244-51. PubMed ID: 24996051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.